Peter Frost

Abbott to sell generics in major markets to Mylan for $5.3 billion

June 18, 2018 at 2:04 p.m.

Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion. The...

Abbott near multibillion-dollar deal to sell drug assets

December 24, 2018 at 12:34 a.m.

Abbott Laboratories is in advanced talks to sell its multibillion-dollar portfolio of generic drugs to Mylan Inc., according to a report from Reuters, citing people familiar with the matter. The...

Exterior of the Abbott Lab's North Chicago campus in North Chicago on Wednesday, January 26, 2011.

Abbott Labs to build dairy farms in China

June 17, 2018 at 6:10 p.m.

Abbott Laboratories is getting into the dairy farming business. The Lake County medical products giant said Thursday it has partnered with New Zealand-based Fonterra Co-Operative Group Ltd. to develop up...

Abbott Labs to build dairy farms in China

November 4, 2021 at 2:00 a.m.

Abbott Labs to build dairy farms in China

December 24, 2018 at 12:33 a.m.

AbbVie forced to retract claims of Shire investor support

June 18, 2018 at 2:28 p.m.

AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his...

Baxter buys drug company with sickle cell treatment

June 17, 2018 at 5:13 p.m.

Baxter International Inc. said Wednesday it has acquired AesRx LLC, a small Massachusetts-based pharmaceutical firm focused on orphan drug treatments, for an undisclosed amount. AesRx's most-promising treatment is a first-in-class...

AbbVie forced to retract claims of Shire investor support

December 24, 2018 at 12:31 a.m.

AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his...

Baxter buys drug company with sickle cell treatment

December 24, 2018 at 12:30 a.m.

AbbVie raises bid for drugmaker Shire to $51 billion

June 17, 2018 at 5:58 p.m.

AbbVie Inc. on Tuesday said it upped its takeover offer for Shire Plc by nearly 11 percent to more than $51 billion, remaining steadfast in its effort to sway the...

All Stories